$ News

Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance

Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results

Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results

Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript

Q3 2024 Accelerate Diagnostics Inc Earnings Call

Accelerate Diagnostics Inc (AXDX) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics Reports Third Quarter 2024 Financial Results

Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results

Accelerate Diagnostics Inc (AXDX) Q2 2024 Earnings Call Highlights: Strategic Advances Amid ...

Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System

FDA approves Accelerate Arc system to identify microbial infections

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System

Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc? System

Accelerate Diagnostics announces FDA clearance of Accelerate Arc system

US settles with billionaire Carl Icahn for using company to secure personal loans worth billions

Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial

Accelerate Diagnostics, Inc. (AXDX) Q2 2024 Earnings Call Transcript

AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024